1. Home
  2. ASMB vs TRTX Comparison

ASMB vs TRTX Comparison

Compare ASMB & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$20.29

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Logo TPG RE Finance Trust Inc.

TRTX

TPG RE Finance Trust Inc.

HOLD

Current Price

$6.24

Market Cap

471.4M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
TRTX
Founded
2005
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
471.4M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
ASMB
TRTX
Price
$20.29
$6.24
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
★ $52.00
$9.54
AVG Volume (30 Days)
202.1K
★ 1.4M
Earning Date
11-09-2026
10-26-2026
Dividend Yield
N/A
★ 16.41%
EPS Growth
★ 91.78
N/A
EPS
N/A
★ 0.19
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.31
P/E Ratio
★ N/A
$30.71
Revenue Growth
N/A
N/A
52 Week Low
$19.94
$5.57
52 Week High
$39.71
$9.37

Technical Indicators

Market Signals
Indicator
ASMB
TRTX
Relative Strength Index (RSI) 31.31 46.61
Support Level N/A $5.57
Resistance Level $30.36 $8.74
Average True Range (ATR) 1.10 0.21
MACD 0.10 0.07
Stochastic Oscillator 7.07 87.59

Price Performance

Historical Comparison
ASMB
TRTX

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.

Share on Social Networks: